2Genevee C,Diu A, Nierat J, et al. An experimentally validated panel of subfamily-specific oligonucleotide primers (Valpha 1-w29/Vbeta 1-w24) for the study of human T cell receptor variable V gone segment usage by polymerase chain reaction[J], Eur J Immunol,1992,22(5):1261-1269.
3Rosenfeld S, Follmann D, Nunez O, et al. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome [J]. JAMA,2003,289(9) ,1130-1135.
4Hirano N, Butler MO, Von Bergwelt-Baildon MS, et al. Autoantibodies frequently detected in patients with aplastic anemia[J]. Blood,2003,102(13) :4567-4575.
5Nagy SM Jr, fisher JJ. Aplastic anemia and immunosuppression [J]. JAMA,2003,290(2) ,193.
6Pannetier C, Levraud JP, Lim A, et al. The immunonoscope approach for the analysis of T cell repertoires [A]. In:Oksenberg JR. The antigen T cell receptor: selected protocols and applications[M]. Austin, TX : Chapman and Hall, 1997. 287-325.
7Manz CY,Dietrich PY,Schnuriger V,et al. T-cell receptor beta chain variability in bone marrow and peripheral blood in severe acquired aplastic anemia[J]. Blood Cells Mol Dis, 1997,23 (1) : 110-122.
8Kook H,Risitano AM,Zeng W,et al. Changes in T-cell receptor VB repertoire in aplastic anemia: effects of different immunosuppressive regimens [J]. Blood, 2002, 99 (10) : 3668- 3675.
9Zeng W,Maciejewski JP,Chen G,et al. Limited heterogeneity of T cell receptor BV usage in aplastic anemia[J]. J Clin Invest, 2001,108(5) : 765-773.
